HIL Medical is an R&D-stage medical-technology startup, on an accelerated growth path. We are developing a new class of compact, high-performance cancer proton-therapy systems. HIL applies a patented particle acceleration and beam delivery approach, combining nano-technology with Nobel-Prize-winning ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility. Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. Affordable single-room systems are key to widespread adoption of this important therapy, and an enabler of a $10BB market (US). HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. We are headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).